Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IVV | Sell | ISHARES TRcore s&p500 et | $60,355,528 | -50.1% | 140,548 | -48.2% | 69.16% | -22.2% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $5,861,023 | – | 40,133 | – | 6.72% | – |
| AKRO | New | AKERO THERAPEUTICS INC | $5,251,013 | – | 103,816 | – | 6.02% | – |
| ETNB | New | 89BIO INC | $1,953,407 | – | 126,516 | – | 2.24% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IVV | New | ISHARES TRcore s&p500 et | $120,844,461 | – | 271,128 | – | 88.92% | – |
| New | NU HLDGS LTD | $15,064,117 | – | 1,909,267 | – | 11.08% | – |